Atlas Trials

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Clinical trial NCT00094549 · COMPLETED

Trial details

NCT number
NCT00094549
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2004-10-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.